🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial is designed as a multi-center, open label Phase 2 trial that inve...
Status
Completed
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Start Date
2011-07
Trial ID
NCT01417936
Treatments Being Tested
Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04148898
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
This is a single-arm, multicenter, phase II study designed to evaluate the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07542717
Treatments Being Tested
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
This is an open-label, multi-center study to evaluate the safety, tolerabil...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2021-11-03
Trial ID
NCT05099549
The purpose of this study is to determine if a new drug, RO4929097, can wor...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2010-09
Trial ID
NCT01198535
The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-07-01
Trial ID
NCT04337658
Treatments Being Tested
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested